WE ASPIRE TO CURE CANCER
Live / Registered — Registered and renewed (as of 09 Mar 2020)
What this means for you
Registered since 19 Jan 2010. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 19 Jan 2020).
Record
- Serial number
- 77732357
- Registration number
- 3739198
- Mark type
- Stylized text
- Filed
- 08 May 2009
- Published for opposition
- 03 Nov 2009
- Registered
- 19 Jan 2010
- Next maintenance due
- 19 Jan 2020
- Attorney of record
- Karl M. Zielaznicki, Esq.
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical research and development; medical and scientific research, namely, conducting clinical trials; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical drug development services
Owner
- Millennium Pharmaceuticals, Inc., Cambridge, MA, US
- Millennium Pharmaceuticals, Inc., Cambridge, MA, US
- Millennium Pharmaceuticals, Inc., Cambridge, MA, US
Prosecution history
- 09 Mar 2020 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 09 Mar 2020 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 09 Mar 2020 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 09 Mar 2020 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 15 Jan 2020 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 15 Jan 2020 — TEAS SECTION 8 & 9 RECEIVED
- 22 Aug 2019 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 22 Aug 2019 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 19 Jan 2019 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 05 Apr 2017 — REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
- 31 Jan 2017 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 27 Mar 2015 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 27 Mar 2015 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 27 Mar 2015 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 13 Mar 2015 — TEAS SECTION 8 & 15 RECEIVED